Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

NCT00967616 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Neoplasms, Colorectal

Interventions

DRUG: CS7017
DRUG: irinotecan, leucovorin, and 5-fluorouracil (5-FU) (FOLFIRI)

Sponsor

Daiichi Sankyo